The Unpopular Truth About Nicotine for Fat Loss (untold story)

DeLauer bases this protocol on his personal experimentation and the research he cited. He notes that the fat loss and cognitive benefits occur at low doses, and that the effects persist after the peak due to sustained low-level receptor activation. He warns that addiction potential is real, so he limits use to specific high-need situations. He also suggests that those with insulin resistance should monitor their response.

DeLauer explains that nicotine binds to nicotinic acetylcholine receptors, particularly the alpha-7 subtype, which triggers acetylcholine release. He cites a study on archers where 2 mg nicotine improved cognitive test scores by 9-11%, and a baseball player study where nicotine gum improved reaction time and hitting accuracy. A rodent study showed that knocking out the alpha-7 receptor gene abolished nicotine's cognitive benefits, confirming the specific pathway. He emphasizes that this receptor activation leads to a cascade of downstream effects, making nicotine 'directive'—it enhances whatever task you're doing, whether sprinting, cognitive work, or emotional regulation. This explains its broad appeal and addictive potential.

DeLauer details a rodent study where nicotine prevented weight gain during overfeeding and led to 12% body fat loss in non-overfed animals, with no change in energy expenditure or lean mass loss. The key was a shift in respiratory exchange ratio, indicating greater fat oxidation. Remarkably, fat loss continued for hours after nicotine administration, even though its half-life is under an hour. He explains that only a very low dose is needed to trigger lipolysis via alpha-7 nicotinic receptors on white adipose tissue, so the declining concentrations after the peak still stimulate fat release. He also mentions that nicotine's metabolite cotinine may contribute to fat loss, though more research is needed. This mechanism explains why smokers often stay lean.

DeLauer references a study in Sports Medicine Open showing nicotine improved peak power and time to exhaustion. He then discusses a potential mechanism: within minutes of administration, nicotine caused an alkaline shift in the body, which could buffer hydrogen ions and lactate during high-intensity exercise, delaying fatigue. However, he acknowledges that the effect might also be purely cerebral, allowing better focus and pushing harder. The alkaline shift is an emerging area of research.

DeLauer stresses that cigarettes contain hundreds of harmful compounds, while pure nicotine is a single molecule acting on specific receptors. He claims many supplements on the market are probably more dangerous than nicotine. However, he warns that nicotine is highly addictive, comparable to caffeine but with a more prolonged addiction quality. He also cites a study in Circulation linking nicotine to hyperinsulinemia and potential cardiovascular risk, advising those with metabolic issues to monitor insulin. He concludes that nicotine requires great responsibility and is not for daily use.

DeLauer reveals that he uses nicotine sparingly, at a dose of a quarter to half a milligram, which is far lower than the 2 mg used in studies. He uses it when he wants an extra edge during intense workouts or to help with appetite suppression while fasting. He emphasizes that he does not use it every day and advises against casual use without research. This protocol aligns with the low-dose fat loss mechanism he described.